HUTCHMED (SEHK:13) Announces Vesting of LTIP Awards

Bulletin Express
10/21

On October 21, 2025, HUTCHMED (China) Limited published an announcement regarding the vesting of certain non-performance based awards granted on October 20, 2021, under its Long Term Incentive Plan. According to the announcement, the awards vested on October 20, 2025.

The directors named in the announcement—Non-executive Director Dr. Dan Eldar, Non-executive Director Ms. Edith Shih, and Independent Non-executive Director Professor Tony Mok—each received 1,938 American depositary shares (ADS). For Ms. Shih, the ADS were issued to her employer, Hutchison International Limited. HUTCHMED is a commercial-stage biopharmaceutical company focused on targeted therapies and immunotherapies for cancer and immunological diseases. Further details appear in the official announcement dated October 21, 2025.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10